Skip to main content
Equibles

Allianz Asset Management GmbH

Position in DHR — Danaher Corp /De/

CIK 1535323 MUNICH, 2M
Back to DHR Full portfolio

Position in DHR

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$12,435,677
-$6,432,366 QoQ
Shares Held
65,286
-34.4% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#420
of 2,106 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 73% Shared 0% None 27%

Common Shares in DHR Over Time

Shares Held

Position Value (USD)

Derivatives in DHR

reported options exposure · as of Jun 30, 2026
CallValue
$8,647,792
CallShares
45,400
PutValue
$12,533,584
PutShares
65,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

Allianz Asset Management GmbH holds $665,369,236 across 21 Diagnostics & Research names. DHR ranks #8 (1.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 526,918 $264,175,606
2 IQV
Iqvia Holdings Inc.
 563,844 $108,945,936
3 IDXX
Idexx Laboratories Inc /De
 145,168 $76,422,240
4 A
Agilent Technologies, Inc.
 400,557 $53,205,984
5 LH
Labcorp Holdings Inc.
 128,335 $35,933,800
6 CSTL
Castle Biosciences Inc
 879,258 $20,970,302
7 GH
Guardant Health, Inc.
 109,240 $16,389,277
8 DHR
Danaher Corp /De/
This page 		65,286 $12,435,677

All Filings in DHR

Export CSV
46 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,647,792 45,400
2026-06-30 $12,533,584 65,800
2026-06-30 $12,435,677 65,286
2026-03-31 $9,859,200 52,000
2026-03-31 $6,503,280 34,300
2026-03-31 $18,868,043 99,515
2025-12-31 $22,851,252 99,822
2025-12-31 $6,661,572 29,100
2025-12-31 $8,264,012 36,100
2025-09-30 $7,831,270 39,500
2025-09-30 $5,055,630 25,500
2025-09-30 $34,410,996 173,565
2025-06-30 $10,153,556 51,400
2025-06-30 $5,669,398 28,700
2025-06-30 $57,600,687 291,590
2025-03-31 $61,160,315 298,343
2025-03-31 $9,368,500 45,700
2025-03-31 $7,605,500 37,100
2024-12-31 $109,788,711 478,278
2024-12-31 $3,626,890 15,800
2024-12-31 $8,103,115 35,300
2024-09-30 $2,724,596 9,800
2024-09-30 $139,084,228 500,267
2024-09-30 $4,809,746 17,300
2024-06-30 $4,247,450 17,000
2024-06-30 $157,210,115 629,218
2024-06-30 $3,522,885 14,100
2024-03-31 $159,909,948 640,357
2024-03-31 $174,804 700
2024-03-31 $299,664 1,200
2023-12-31 $141,804,708 612,971
2023-09-30 $175,978,808 709,306
2023-06-30 $172,122,513 717,177
2023-03-31 $173,771,986 689,462
2022-12-31 $182,871,709 688,990
2022-09-30 $177,789,789 688,334
2022-06-30 $228,833,769 902,626
2022-03-31 $281,334,532 959,106
2021-12-31 $303,349,158 922,006
2021-09-30 $248,651,352 816,750
2021-06-30 $210,061,740 782,761
2021-03-31 $138,874,576 617,001
2020-12-31 $131,860,953 593,594
2020-09-30 $120,748,455 560,760
2020-06-30 $119,561,139 676,136
2020-03-31 $108,690,463 785,279

Report a Problem

Category
Description
Email (optional, for follow-up)